Sign In
NewsRadar

Press release centre

Search Press
Looking for press releases of a particular company? Enter company name (or keyword) here.
   

Past Press Releases - ProBioGen AG

September 9, 2014
20 Years ProBioGen: Invests €20 Million in Mammalian Manufacturing Expansion
On the occasion of its 20th anniversary, ProBioGen AG announced to invest 20 million and to double its workforce. More

June 23, 2014
ProBioGen Signs GlymaxX ADCC Enhancement Technology License Deal
ProBioGen AG announced today that it has signed a non-exclusive commercial multi-product licensing agreement with Novartis on its GlymaxX Antibody Glyco-Engineering technology. More

February 20, 2013
ProBioGen Signs Next GlymaxX ADCC Technology Deal with TOP 10 Pharma Company for Therapeutic ...
ProBioGen Signs Next GlymaxX ADCC Technology Deal with TOP 10 Pharma Company for Therapeutic Antibody Platform. More

November 12, 2012
ProBioGen Launches Unique Portfolio of Engineered High-Performance Cell Lines
ProBioGen Launches Unique Portfolio of Engineered High-Performance Cell Lines for Biopharmaceutical Manufacturing. More

June 16, 2010
Minapharm Pharmaceuticals acquires majority stake in ProBioGen – Dr. Wieland Wolf appointed new CEO
roBioGen AG announced today that Minapharm Pharmaceuticals, Cairo, has completed the acquisition of 95 % of the share capital of ProBioGen, an internationally renowned German cell line development and contract manufacturing specialist. More

April 1, 2010
ProBioGen is granted divisional patent on its proprietary AGE1 cell line
ProBioGen AG, a leading biotechnology company in cell engineering and production of biopharmaceuticals, today announced that it has been granted a divisional patent on its AGE1 cell line. More

November 24, 2009
ProBioGen presents new data on its Human Artificial Lymph Node (HuALN) technology
Integrated model for the comprehensive evaluation of vaccines. More

December 18, 2008
Rhein Minapharm and ProBioGen announce additional cell line development agreement
Rhein Minapharm Biogenetics SAE and ProBioGen today announced that they have closed their third cell line development agreement. More

July 10, 2008
Patent granted for ProBioGen's avian cell line AGE1.CR
ProBioGen AG, a leading biotechnology company in cell engineering and production of biopharmaceuticals, has been granted patent protection for AGE1.CR, a proprietary duck cell line developed for the production of human and animal vaccines and proteins. More

Data


26,231
Tech investments
From our Online Data Service
16,945
VC-backed companies
From our Radar


Recent Deals


DATEAMOUNTSECTOR
Oct 11N/AInternet services
Oct 11€1.1MKnowledge management
Oct 11N/AInternet services
Oct 11€13.0MBiotechnology
Oct 11N/AMedical devices
Oct 10€50.0MInternet services
Oct 10€23.0MOther Computers & Electronics

For information on Europe's most extensive database on technology funding click here!

Events



Press Releases


May 28
Identiq
identiq raises $5m seed, launches privacy-first identity validation...

Apr 29
Nethone
nethone raised over $1 million from innovation nest

Oct 1
The Link App
the link app launches version 2.0

Mar 29
Addex Therapeutics
addex sucessfully raises chf40 million in capital increase

Jan 2
Urban Jungle
urban jungle raises 1m in seed funding to build tech-enabled home ...





About usContact usLegal Information
Copyright 1999-2019
Emerging Technology Research Europe Inc. All rights reserved.